跳至主要内容
临床试验/NCT04564118
NCT04564118已完成不适用

A Retrospective Analysis of the Adherence to Clinical Practice Guidelines Using the "MedicBK" Digital Platform in Patients With Hypertension and Atrial Fibrillation (the INTELLECT Trial)

Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health1 个研究点 分布在 1 个国家目标入组 191 人开始时间: 2020年9月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
191
试验地点
1
主要终点
Assessment of AF/AH treatment guidelines compliance

研究概览

简要总结

The Clinical Decision Support Systems (CDSS) based on real clinical data and its own algorithms can help to make the right choice. This trial is designed to assess the difference between retrospective electronic medical cards (EMC) therapy prescriptions and MedicBK prescriptions based on key patient characteristics.

详细描述

There is a lot of data from registries about poor adherence to guidelines. It is connected with a problem that patients usually have a lot of comorbidities and physicians need to know сonsequently the huge number of medications and combinations. It is very difficult to decide quickly according to available data from libraries like PubMed. The Clinical Decision Support Systems (CDSS) based on real clinical data and its own Artificial Intelligence algorithms can help to make the right choice. This trial is designed to assess the difference between retrospective electronic medical cards (EMC) therapy prescriptions and MedicBK prescriptions based on key patient characteristics.

Two groups of experts (cardiologists with clinical practice for more than 5 years) will be participating in the trial.

Using main characteristics from EMC the first group of experts will put this data into MedicBK platform and assess retrospective treatment. The next blinded group of experts will perform prescriptions using MedicBK algorithms based on current guidelines and data from available clinical trials. The main hypothesis is the use Clinical Decision Support Systems (CDSS) better than current clinical practice. This option can help to make the right choice of medical combination based on main patient's clinical characteristics

研究设计

研究类型
Observational
观察模型
Other
时间视角
Other

入排标准

年龄范围
19 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age > 18 years old
  • Patients diagnosed with nonvalvular atrial fibrillation and essential hypertension having indications for therapy according to European guidelines.

排除标准

  • Valvular cause of atrial fibrillation
  • GFR less than 30 ml / min
  • Active liver disease
  • Acute coronary syndrome
  • The presence of thyroid diseases as a cause of atrial fibrillation
  • Secondary arterial hypertension

研究组 & 干预措施

Group 1

retrospective data on treatment from EMC

干预措施: Retrospective analysis of assigned treatment (Drug)

结局指标

主要结局

Assessment of AF/AH treatment guidelines compliance

时间窗: 1 MONTH

Number of electronic medical records not compliant to the AF/AH clinical practice guidelines

次要结局

  • Assessment of MedicBK programme(1 MONTH)

研究者

发起方
Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验